HUM - Humana Inc.

NYSE - NYSE Delayed Price. Currency in USD
249.89
+1.44 (+0.58%)
At close: 4:01PM EDT

249.89 0.00 (0.00%)
After hours: 6:08PM EDT

Stock chart is not supported by your current browser
Previous Close248.45
Open248.81
Bid248.82 x 1000
Ask248.87 x 1200
Day's Range246.85 - 251.11
52 Week Range225.65 - 355.88
Volume1,114,794
Avg. Volume1,311,280
Market Cap33.895B
Beta (3Y Monthly)1.11
PE Ratio (TTM)20.55
EPS (TTM)12.16
Earnings DateMay 1, 2019
Forward Dividend & Yield2.00 (0.75%)
Ex-Dividend Date2019-06-27
1y Target Est359.75
Trade prices are not sourced from all markets
  • Anthem's (ANTM) Q1 Earnings Beat Estimates, Improve Y/Y
    Zacks9 hours ago

    Anthem's (ANTM) Q1 Earnings Beat Estimates, Improve Y/Y

    Anthem's (ANTM) Q1 earnings surge on the back of a solid operating performance and strong growth across all core businesses.

  • Humana (HUM) Reports Next Week: Wall Street Expects Earnings Growth
    Zacks10 hours ago

    Humana (HUM) Reports Next Week: Wall Street Expects Earnings Growth

    Humana (HUM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Humana and Doctor on Demand Launch Virtual Primary Care Plan to Bring More Services with Lower Costs to Patients, Insurers, and Employers
    Business Wire11 hours ago

    Humana and Doctor on Demand Launch Virtual Primary Care Plan to Bring More Services with Lower Costs to Patients, Insurers, and Employers

    Doctor On Demand® and Humana Inc. (HUM) today announced the launch of On Hand™, an innovative and affordable health plan that centers on comprehensive virtual primary care. This new plan design represents a paradigm shift in healthcare where patients will have access to comprehensive, quality care from doctors without having to visit a doctor’s office, available at significantly lower monthly premiums. “By partnering with Doctor On Demand, Humana is leading the market with a modern approach to meeting the health plan needs of employers and employees,” said Chris Hunter, Humana’s Group & Military segment president.

  • Telemedicine startup Doctor on Demand taps giant health partner to debut virtual primary care plan
    American City Business Journals11 hours ago

    Telemedicine startup Doctor on Demand taps giant health partner to debut virtual primary care plan

    Humana’s Florida and Texas markets will be Doctor On Demand’s first test of the virtual primary care experience for patients.

  • Is a Beat Likely for Universal Health (UHS) Q1 Earnings?
    Zacksyesterday

    Is a Beat Likely for Universal Health (UHS) Q1 Earnings?

    Universal Health's (UHS) Q1 is likely to gain traction from higher admissions as well as licensed beds. However, the same might be partially offset by escalating costs.

  • Centene's (CNC) Q1 Earnings Beat Estimates, Increase Y/Y
    Zacksyesterday

    Centene's (CNC) Q1 Earnings Beat Estimates, Increase Y/Y

    Centene's (CNC) first-quarter earnings top on solid revenue growth.

  • GuruFocus.com2 days ago

    5 Worst-Performing Health Insurance Stocks of 2019

    Health care has lagged the market more than any other sector this year

  • Business Wire2 days ago

    Humana’s 2019 Bold Goal Progress Report Details A Focus On Social Determinants of Health and Improved Healthy Days in its Medicare Advantage Population

    LOUISVILLE, Ky.-- -- Five of Humana’s seven original Bold Goal communities reduced Unhealthy Days Humana Medicare members in San Antonio achieved a 9.8 percent improvement Screened 500,000 people for social determinants of health across Bold Goal communities and Humana, setting a new goal of 1 million by the end of 2019 Humana Inc. today unveiled the “2019 Bold Goal Progress Report,” which details ...

  • Barrons.com5 days ago

    Health Insurers’ Stocks Have Been Battered. Now They Look Like a Buy.

    Shares of UnitedHealth, Cigna, Anthem, and others have weakened on fear of Medicare for All. But the odds are that this political fever will abate.

  • Business Wire6 days ago

    Humana Board Declares Payment of Quarterly Dividend to Stockholders

    Humana Inc. announced today that its Board of Directors has declared a cash dividend to stockholders of $0.55 per share payable on July 26, 2019 to stockholders of record as of the close of business on June 28, 2019.

  • Is a Beat in the Cards for Anthem's (ANTM) Q1 Earnings?
    Zacks6 days ago

    Is a Beat in the Cards for Anthem's (ANTM) Q1 Earnings?

    Anthem's (ANTM) first-quarter earnings are likely to benefit from an impressive operating performance and robust revenues, driven by its strong businesses.

  • Why ‘Scared’ Investors May Push Health Care Stocks Even Lower
    Investopedia8 days ago

    Why ‘Scared’ Investors May Push Health Care Stocks Even Lower

    While the broad market zooms ahead, health care stocks are being weighed down by regulatory threats even as earnings forecasts remain strong.

  • Why Humana (HUM) is Poised to Beat Earnings Estimates Again
    Zacks8 days ago

    Why Humana (HUM) is Poised to Beat Earnings Estimates Again

    Humana (HUM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

  • Investing.com8 days ago

    StockBeat - UnitedHealth Tumbles After CEO Sounds Alarm on Medicare for All

    Investing.com - UnitedHealth fell Tuesday, giving up early post-earnings gains as political concerns overshadowed solid results.

  • EverlyWell scores $50M haul
    American City Business Journals9 days ago

    EverlyWell scores $50M haul

    CEO Julia Taylor Cheek founded EverlyWell in 2015. Her company enables people to order tests, such as fertility and food-sensitivity diagnostics, and obtain doctor-reviewed results and feedback within days.

  • GuruFocus.com9 days ago

    52-Week Company Lows

    According to GuruFocus' list of 52-week lows, these guru stocks have reached their 52-week lows. The price of UnitedHealth Group Inc. (UNH) shares has declined to close to the 52-week low of $223.22, which is 23.3% off the 52-week high of $287.94. The company has a market cap of $214.19 billion.

  • There’s a Buy the Dip Opportunity in Walgreens Stock but It Isn’t Now
    InvestorPlace10 days ago

    There’s a Buy the Dip Opportunity in Walgreens Stock but It Isn’t Now

    April started poorly for Walgreens Boots Alliance (NASDAQ: WBA). A weak second-quarter earnings report sent Walgreens stock down 12.8% on April 2. With a downtrend very clearly in place, why should investors even consider WBA stock after the plunge?Source: Mike Mozart via FlickrWalgreens reported non-GAAP earnings of $1.64 as revenue grew 4.6% to $34.53 billion. A confluence of negative headwinds hit the company's bottom line. Higher reimbursement pressures, lower generic deflation, lower brand inflation and weak performance from restructuring programs led to the poor results. * 7 Marijuana Companies: Which Pot Stocks Should You Buy? Markets now know why Walgreens, along with CVS (NYSE: CVS) and Rite Aid (NYSE: RAD) fell ahead of the results report. Markets even sold off health care plan stocks like Cigna (NYSE: CI) and Humana (NYSE: HUM) in 2019: there are significant market-wide headwinds.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Long-Term Growth and Walgreens StockWalgreens has four strategic priorities aimed at delivering sustainable, long-term growth. It is accelerating the company's digital footprint, transforming its approach to retail, creating neighborhood health destinations, and implementing a revamped cost management program.This jargon on cost reduction will not mean much to the shareholder who just lost 12.8%.To stabilize the business as reimbursement pressures worsen, Walgreens must improve same-store sales. The near-term problems in achieving growth here are the acquired Rite Aid stores. Sales grew 7.3% and organic sales grew 1.6% but adjusted growth profit declined a substantial 3.5% in the quarter. Pharmacy and retail both fell. Gross margin from Pharmacy fell 260 basis points.A 6.8% drop in SG&A spend, along with cost savings initiatives ahead may slow the weakening operating income, which fell 11.9% in the second quarter. Opportunity and Walgreens StockA weaker cough, cold, and flu season added to Walgreens' woes but could create an opportunity for value investors. Since results were so weak, Walgreens could move up from here if management moves swiftly to balance its operating expenses against the higher reimbursement pressure.Digitization will help Walgreens increase its efficiency but it needs more than that. Still, bringing in the Microsoft (NASDAQ: MSFT) Teams to consolidate its internal digital team under a Chief Digital Officer will improve back-office efficiency.Walgreens restructured management such that there are two teams in development and delivery. One accomplishment is that its 5-star rated app has 55 million downloads. Another is it has 85 million active Balance Rewards members. The drug store clearly has the potential to reach out to its customer base through the mobile app. What is not clear yet is how much more business the app will bring for Walgreens. Near-term OutlookThe weak current third quarter for Walgreens will follow with improvements in Q4. While investors are disturbed by management's realistic goal-setting of mid-to-high single-digit growth, the reset in expectations creates an entry point for value investors.Plus, with the company working to offset the generic impact by 50% - 60%, profit margins may start to stabilize. Overall, it plans to cut costs by $1.5 billion. That is a substantial number and will benefit the company's long-term health.Walgreens will also shift its resources towards growing its Health & Beauty segment where it is confident that it can win an already very attractive business. The Bottom Line on Walgreens StockThe analyst positional changes are mixed. According to Tipranks, one analyst called WBA stock a "sell" while six have a "hold" and two analysts have a "buy." The average price target is $61 a share, which suggests the stock has an upside of 11%.Patient investors may want to wait for the selling-pressure to ease for a few days. Walgreens is already trading at a discount but this could widen. Still, even though drug store stocks are out of favor, Walgreens is the strongest of the available picks.Disclosure: As of this writing, the author did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Internet Stocks to Watch * 7 AI Stocks to Watch with Strong Long-Term Narratives * 10 Dow Jones Stocks Holding the Blue Chip Index Back Compare Brokers The post There's a Buy the Dip Opportunity in Walgreens Stock but It Isn't Now appeared first on InvestorPlace.

  • ETF Trends12 days ago

    Healthcare ETFs Deteriorate on Congress’ Threats to Drug Prices

    Healthcare sector-specific ETFs took a blow Friday after the U.S. Congress threatened legislative action on rising costs of prescription drugs and the Trump administration challenged former President Barack ...

  • The Zacks Analyst Blog Highlights: McDonald's, Enterprise Products Partners, Charles Schwab, BB&T and Humana
    Zacks12 days ago

    The Zacks Analyst Blog Highlights: McDonald's, Enterprise Products Partners, Charles Schwab, BB&T and Humana

    The Zacks Analyst Blog Highlights: McDonald's, Enterprise Products Partners, Charles Schwab, BB&T and Humana

  • Healthcare Stocks in Focus on Regulatory and Political Risk
    Zacks12 days ago

    Healthcare Stocks in Focus on Regulatory and Political Risk

    Healthcare stocks suffered declines in the Medicare-for-All policy and revving up of drug price rebate.

  • Asian stocks mostly higher after mixed Wall Street day
    Associated Press13 days ago

    Asian stocks mostly higher after mixed Wall Street day

    Asian stock markets were mostly higher Friday after a mixed Wall Street close on listless trading. Benchmarks in Tokyo, Sydney and Seoul rose. China's main index was up 1 point while Hong Kong retreated. ...

  • Doctor on Demand CEO: Partnering with Humana on virtual services
    CNBC Videosyesterday

    Doctor on Demand CEO: Partnering with Humana on virtual services

    Doctor on Demand CEO Hill Ferguson breaks down how his private company's deal with Humana will leverage the health insurer's large network in the emergency room.

  • The shadowy system behind the high price of your drugs
    Yahoo Finance Video12 days ago

    The shadowy system behind the high price of your drugs

    Healthcare stocks are taking a hit this week. Proposed legislation that would tighten control over pharmacy benefit managers-- or PBMs-- are weighing down shares. Who are PBMs and what impact do they have on what we pay for our prescription drugs? Robin Feldman, author of Drugs, Money and Secret Handshakes, the Unstoppable Growth of Prescription Drug Prices, talks with Yahoo Finance's Julie Hyman and Adam Shapiro.